The reasons for switching to DRd in the three patients who achieved PR to VCd were that the serum M-protein level reached a plateau at a high level in two patients, and the other patient was intolerant owing to nausea and peripheral neuropathy. This evidence concerns the gene MYOM2 and peripheral neuropathy.